Year
Edition number
№4 / 2026
ORIGINAL STUDIES
A.V. Yagoda, E.O. Demurcheva, P.V. Koroy, T.R. Dudov
BsmI polymorphism of the vitamin D receptor gene in non-alcoholic fatty liver disease associated with type 2 diabetes mellitus9-18
N.I. Khutsishvili, I.S. Nazarov, A.F. Safarova, V.V. Tolkacheva, E.I. Luchina, Zh.D. Kobalava
The role of HFA-PEFF and H2FPEF scales in the diagnosis of heart failure with preserved ejection fraction and prediction of cardiovascular outcomes in patients with type 2 diabetes mellitus and suspected heart failure with preserved ejection fraction19-27
G.A. Slonimskaya, I.A. Kurnikova, V.A. Kokorin, T.A. Meleshkevich, V.A. Mayorov, A.F. Pavlov
Prognostic cardiovascular risks in patients with type 2 diabetes mellitus depending on the type of hypoglycemic therapy28-35
P.K. Akhmedova, A.S. Ametov, N.A. Chernikova, T.N. Korotkova
Influence of dipeptidyl peptidase-4 inhibitor on fat metabolism and Its role in glucose metabolic regulation: Results of the study36-43
A.S. Gusev-Shcherbakov, E.A. Troitskaya, Zh.D. Kobalava
Influence of thyroid-stimulating hormone level on the lipid profile, arterial stiffness, and central blood pressure in case of subclinical hypothyroidism44-54
A.V. Tanich, A.N. Kuchmin, E.P. Galova, M.B. Nagorny, A.A. Kazachenko
Geometric parameters and diastolic cardiac function indexes in individuals with obstructive sleep apnea syndrome and obesity55-63
A.I. Zagrebneva, E.N. Simonova, Yu.A. Gavrikova, V.V. Dolgov, A.A. Buyanova, O.D. Dukhanina, E.L. Isakulyan, R.R. Samigullina, V.I. Mazurov
From basic therapy to genetically engineered biological drugs: Predicting response in a cohort of patients with rheumatoid arthritis not meeting D2TRA criteria64-81
REVIEWS
V.V. Salukhov, E.A. Troshina, R.V. Rozhivanov, G.A. Melnichenko
Personalized treatment of hypogonadism in obese male individuals: An algorithm for the combined use of incretin mimetics and testosterone medications82-96
K.Sh. Dzampaeva, E.V. Bondarenko, N.M. Platonova
Procalcitonin metabolites and macrocalcitonin in the diagnosis of hypercalcitoninemia of various origins98-104
D.V. Ivanova, A.N. Zvyagintseva, G.R. Galstyan, O.K. Vikulova, M.V. Shestakova
Do climatic and geographical factors influence the risk of developing diabetes mellitus?105-116
S.A. Nedomolkina, A.A. Pashkova, O.V. Velikaya, A.V. Velikiy
Non-drug methods for the prevention of type 2 diabetes mellitus in therapeutic practice117-124
GUIDELINES FOR PRACTITIONERS
A.A. Koval, L.G. Ebanoidze, E..A. Pigarova, L.K. Dzeranova, E.G. Przhiyalkovskaya, V.N. Azizyan, A.Yu. Grigoriev, A.V. Khairieva, N.V. Tarbaeva
Central pontine and extrapontine myelinolysis due to rapid correction of severe hyponatremia: A clinical case125-133
A.S. Ametov, E.Yu. Pashkova, K.A. Amikishieva, A.A. Timoshchuk
Hypertriglyceridemia and dysglycemia: Pathogenic affinities and clinical consequences134-145
E.V. Uzhakova
The role of semaglutide in the treatment of type 2 diabetes mellitus in a female patient with sarcopenia: A clinical case146-151
S.N. Marshal, M.D. Iarovoy, I.V. Semenyakin, E.V. Reznik
Atypical clinical course of polymyalgia rheumatica152-160
LECTURE
R.M. Gabibullaev, A.A. Udagova, P.S. Akhmedova, L.V. Saveleva, S.A. Ibragimova
Von Hippel – Lindau syndrome: A case report reminding the necessity for pheochromocytoma detection in patients with arterial hypertension161-168
S.A. Boldueva, E.G. Bykova, D.S. Evdokimov, I.N. Kochanov, V.A. Kovalev, K.A. Gladysheva, A.E. Steblev
Mönckeberg’s disease: A case report169-175
Guideline for practitioners
A.N. Zvyagintseva, K.V. Melkozerov, I.Z. Bondarenko, O.A. Shatskaya, I.A. Khamnagadaev, V.Yu. Kalashnikov, N.M. Platonova, N.G. Mokrysheva
Amiodarone paradox: Hyperthyroxinemia without thyrotoxicosis – a management strategy analysis based on two clinical cases176-182
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT
N.V. Mazurina, E.A. Troshina
Clinical aspects of semaglutide therapy: How to choose the optimal drug?183-189
